MONICA HALLAC: Open Payments
NPI 1740831528 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 35 payments from 18 companies in 2025. Trend: 2023 $745 · 2024 $531 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $160 |
| ARGENX US, INC. | 4 | $113 |
| Lundbeck LLC | 3 | $73 |
| Lilly USA, LLC | 3 | $51 |
| Alexion Pharmaceuticals, Inc. | 2 | $48 |
| Eisai Inc. | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $43 |
| Grifols USA, LLC | 1 | $29 |
| HOSPIRA, INC. | 1 | $29 |
| Boston Scientific Corporation | 1 | $23 |
Products named: ENTYVIO, HYQVIA, VYEPTI, ULTOMIRIS, Leqembi, TREMFYA, KISUNLA, Gamunex-C.
Industry payments across MI — which companies pay providers there.
